In the absence of BRCA1/2 germline mutations, alterations in other specific homologous recombination (HR) genes, such as PALB2, CHEK2, ATM, and NBN, can lead to an increased risk of breast cancer development [46]. Here, CHEK2 is linked to breast cancer.